Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers

被引:66
|
作者
Scimeca, Manuel [1 ,2 ]
Antonacci, Chiara [1 ,2 ]
Colombo, Daniele [1 ]
Bonfiglio, Rita [1 ]
Buonomo, Oreste Claudio [3 ]
Bonanno, Elena [1 ,2 ]
机构
[1] Univ Roma Tor Vergata, Dept Biomed & Prevent, Anat Pathol Sect, Via Montpellier 1, I-00133 Rome, Italy
[2] Spin Off Univ Tor Vergata, TMALab Srl, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy
关键词
Breast cancer markers; Epithelial to mesenchymal transition; NF-kB; PTX3; K-RAS; Sonic Hedgehog; NF-KAPPA-B; PANCREATIC-CANCER; SIGNALING PATHWAYS; STEM-CELLS; INFLAMMATION; TRANSITION; PRINCIPLES; THERAPY; STATES; PTX3;
D O I
10.1007/s13277-015-4361-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the screening program, breast cancer is the commonest cause of cancer death in women in the industrialized world. In this study, we investigate the correlation among poorly differentiated carcinoma, epithelial to mesenchymal transition (EMT) phenomenon, and expression of NF-kB, Sonic Hedgehog (SHH), K-RAS, and PTX3 in breast cancer in 100 breast biopsies. Samples were classified as follows: 30 benign lesions (BL), 30 ductal infiltrating carcinomas low grade (MLG1), and 40 ductal infiltrating carcinomas high grade (MLG3). Expression of vimentin, CD44, beta-catenin, NF-kB, SHH, K-RAS, CD44, and PTX3 was studied by immunohistochemistry. The different rate of cells with vimentin, nuclear beta-catenin, and CD44 expression in MLG3 as compared with MLG1 and BL suggested that the process of de-differentiation of breast cancer cells could be related to the EMT. Our results showed a significant increase in NF-kB signal in MLG3 (2.33 +/- 0.77) with respect to MLG1 (1.26 +/- 0.55) and BL (0.86 +/- 0.52). SHH expression appeared low in BL (1.00 +/- 0.41) and homogenously widespread in MLG1 (1.23 +/- 0.63) and MLG3 (1.56 +/- 0.54). An important increase in K-RAS signal was observed in MLG3 compared to that in BL (2.20 +/- 0.69 vs 0.82 +/- 0.59). As regards PTX3, we observed a strong expression in MLG3 (2.00 +/- 0.78) with respect to BL (0.58 +/- 0.55) and MLG1 (1.53 +/- 0.76). The recurring expression of NF-kB, SHH, K-RAS, and PTX3 in vimentin- and CD44-positive breast cancer cells allows to speculate that breast cells acquire the ability to express these molecules in concomitance to EMT phenomenon.
引用
收藏
页码:5427 / 5435
页数:9
相关论文
共 50 条
  • [31] Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas
    Fernandes, Raquel C. M.
    Bevilacqua, Jose L. B.
    Soares, Ibere C.
    Siqueira, Sheila A. C.
    Pires, Luis
    Hegg, Roberto
    Carvalho, Filomena M.
    HISTOPATHOLOGY, 2009, 55 (03) : 346 - 352
  • [32] Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer
    Rashed, Hayam E.
    Hussein, Samia
    Mosaad, Hala
    Abdelwahab, Mai M.
    Abdelhamid, Mohamed I.
    Mohamed, Salem Y.
    Mohamed, Abdel Motaleb
    Fayed, Alaa
    CANCER BIOMARKERS, 2017, 20 (01) : 107 - 122
  • [33] Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
    Yosep Chong
    Nishant Thakur
    Kwang Yeol Paik
    Eun Jung Lee
    Chang Suk Kang
    BMC Cancer, 20
  • [34] Prognostic significance of stem cell/epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
    Chong, Yosep
    Thakur, Nishant
    Paik, Kwang Yeol
    Lee, Eun Jung
    Kang, Chang Suk
    BMC CANCER, 2020, 20 (01)
  • [35] STUDY OF THE CORRELATION BETWEEN THE EXPRESSION OF RECOGNIZED MONOCLONAL-ANTIBODY MARKERS AND PROGNOSTIC FACTORS IN BREAST CANCERS
    DADALT, MG
    ANDREOLA, S
    CORADINI, D
    DIFRONZO, G
    MENARD, S
    COLNAGHI, MI
    TUMORI, 1986, 72 (06) : 661 - 661
  • [36] MicroRNAs as therapeutic and prognostic markers for resistance to therapy in HER2/neu positive breast cancers
    Mathranda, S. A.
    Diwakar, R. B.
    Srihari, S.
    Munirathnam, V.
    Simha, V.
    Anantharamu, S.
    Namani, A.
    Devi, D.
    Korlimarla, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1417 - S1417
  • [37] Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma
    Guo, Jianfei
    Lv, Weiqing
    Wang, Zehua
    Shang, Yun
    Yang, Fan
    Zhang, Xiaomin
    Xiao, Keyuan
    Zhang, Shangyunduo
    Pan, Xiaoqi
    Han, Yan
    Zong, Liang
    Hu, Wenqing
    CANCER CONTROL, 2023, 30
  • [38] Microsatellite instability accounts for tumor site-related differences in prognostic markers in human colon cancers
    Sinicrope, Frank A.
    Rego, Rafaela L.
    Foster, Nathan
    Sargent, Daniel J.
    French, Amy
    Garrity, Megan
    Goldberg, Richard M.
    Laurie, John A.
    Burgart, Lawrence J.
    Witzig, Thomas E.
    Thibodeau, Stephen N.
    GASTROENTEROLOGY, 2006, 130 (04) : A720 - A720
  • [39] Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study
    A Stark
    M S Stahl
    H L Kirchner
    S Krum
    J Prichard
    J Evans
    International Journal of Obesity, 2010, 34 : 1381 - 1386
  • [40] Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study
    Stark, A.
    Stahl, M. S.
    Kirchner, H. L.
    Krum, S.
    Prichard, J.
    Evans, J.
    INTERNATIONAL JOURNAL OF OBESITY, 2010, 34 (09) : 1381 - 1386